Clinical Trial Update: Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1) [Phase 2, Phase 3]

View source ↗

Summary

A double-blind, randomized trial evaluating PRAX-628 for efficacy and safety in adults with focal seizures is currently in Phase 2/3 and actively recruiting und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Seizures

Drugs mentioned

• PRAX-628

Snippet

Sponsor: Praxis Precision Medicines | Conditions: Focal Seizure | Phase 2, Phase 3 | Status: RECRUITING